{"database": "openregs", "table": "documents", "rows": [["FDA-2012-D-0880-0021", "FDA", "FDA-2012-D-0880", "Generic Drug User Fee Amendments of 2012: Questions and Answers Related to Self-Identification of Facilities, Review of Generic Drug Submissions, and Inspections and Compliance; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2017-07-26T04:00:00Z", 2017, 7, "2017-07-26T04:00:00Z", null, "2017-07-26T13:59:13Z", "2017-15654", 0, 0, "090000648296a012"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2012-D-0880-0021"], "units": {}, "query_ms": 86.89540880732238, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}